| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pharmacology [S. B. H.], Microbiology and Immunology, and Pediatrics [M. S. H.], Albert Einstein College of Medicine, Bronx New York 10461
Incubation of camptothecin with HeLa cells in either the G1 or S phase of the cell cycle results in fragmentation of DNA as analyzed on alkaline sucrose gradients. Removal of the drug from G1- or S-phase cells results in the normal sedimentation of cellular DNA. Neither the fragmentation nor the repair of HeLa cell DNA requires DNA replication. However, subtle irreversible changes must take place in the DNA in cells treated with camptothecin for 30 min during the S phase, since such cells are unable to undergo subsequent cell division. The lethal effect is presumed to be at the single strand-replication forks.
1 This investigation was supported by USPHS Grants CA-10666 and CA-11502 from the National Cancer Institute.
2 Recipients of Research Career Development Awards GM-11147 and CA-35554 from the NIH.
Received 5/29/73. Accepted 8/20/73.
This article has been cited by other articles:
|
|
 |
|
  T. H. Davis Profile of Susan Band Horwitz PNAS, July 5, 2006; 103(27): 10163 - 10165. [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. El-Khamisy and K. W. Caldecott TDP1-dependent DNA single-strand break repair and neurodegeneration Mutagenesis, July 1, 2006; 21(4): 219 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Deng, M. J. Viar, and L. R. Johnson Polyamine depletion inhibits irradiation-induced apoptosis in intestinal epithelia Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G599 - G606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chatterjee, R. Digumarti, R. N. V. S. Mamidi, K. Katneni, V. V. Upreti, A. Surath, M. L. Srinivas, S. Uppalapati, S. Jiwatani, S. Subramaniam, et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of an Orally Active Novel Camptothecin Analog, DRF-1042, in Refractory Cancer Patients in a Phase I Dose Escalation Study J. Clin. Pharmacol., July 1, 2004; 44(7): 723 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Kang, M. T. Muller, and I. K. Chung Telomeric DNA Damage by Topoisomerase I: A POSSIBLE MECHANISM FOR CELL KILLING BY CAMPTOTHECIN J. Biol. Chem., March 26, 2004; 279(13): 12535 - 12541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Deng, D.-A. Wang, E. Gosmanova, L. R. Johnson, and G. Tigyi LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway Am J Physiol Gastrointest Liver Physiol, May 1, 2003; 284(5): G821 - G829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Rowinsky, J. Rizzo, L. Ochoa, C. H. Takimoto, B. Forouzesh, G. Schwartz, L. A. Hammond, A. Patnaik, J. Kwiatek, A. Goetz, et al. A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid Malignancies J. Clin. Oncol., January 1, 2003; 21(1): 148 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Rowinsky Weekly Topotecan: An Alternative to Topotecan's Standard Daily x 5 Schedule? Oncologist, August 1, 2002; 7(4): 324 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Tardi, E. Choice, D. Masin, T. Redelmeier, M. Bally, and T. D. Madden Liposomal Encapsulation of Topotecan Enhances Anticancer Efficacy in Murine and Human Xenograft Models Cancer Res., July 1, 2000; 60(13): 3389 - 3393. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Hochberg, S. A. Grossman, T. Mikkelsen, M. Glantz, J. D. Fisher, S. Piantadosi, and the NABTT CNS Consortium Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosed glioblastoma multiforme and recurrent high-grade astrocytoma Neuro-oncol, January 1, 2000; 2(1): 29 - 33. [Abstract] [PDF]
|
|
|
|
|
|
R. J. D. Reid, E. A. Kauh, and M.-A. Bjornsti Camptothecin Sensitivity Is Mediated by the Pleiotropic Drug Resistance Network in Yeast J. Biol. Chem., May 2, 1997; 272(18): 12091 - 12099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Ireton, L. Stewart, L. H. Parker, and J. J. Champoux Expression of Human Topoisomerase I with a Partial Deletion of the Linker Region Yields Monomeric and Dimeric Enzymes That Respond Differently to Camptothecin J. Biol. Chem., August 11, 2000; 275(33): 25820 - 25830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Cliby, K. A. Lewis, K. K. Lilly, and S. H. Kaufmann S Phase and G2 Arrests Induced by Topoisomerase I Poisons Are Dependent on ATR Kinase Function J. Biol. Chem., January 4, 2002; 277(2): 1599 - 1606. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
